NCT03026933
Evaluate the Efficacy and Safety of KI1107 in Patients Whose TG Level is Not Adequately Controlled With Rosuvastatin Calcium Monotherapy While LDL-C is Properly Controlled
Phase: Phase 3
Role: Lead Sponsor
Start: May 31, 2014
Completion: Mar 31, 2016